Avsnitt
-
Nathan Rust, Lutz Lehmann, Troy Pospisil, Jeremy Segal, Patrick Mumman, Tej Brahmbhatt, George Helock, and Angie Astle
Eight deal professionals share the M&A moments that never make the CIM. A birthday cake in a management presentation that confirmed a culture fit and influenced a bid. A buyer who died before close, forcing a nine-month restart from scratch. Eight years of customer revenue data on a 1980s IBM that management claimed did not exist. A target quietly heading toward Chapter 11 while diligence was underway. Unexpected events mid-deal are not exceptions. They are the deal. How you read them is what separates experienced practitioners from everyone else.
What You'll Learn:
How cultural signals in a management presentation can influence a bid decision What to do when a buyer dies before close and the sell process has to restart How to find data that management says does not exist Why late-stage valuation surprises from founders are a signal you could have caught earlier How to take a bankrupt target through Chapter 11 and still close the deal Why experienced advisors document every surprise the moment a deal closesIf you're running deals and want pattern recognition built from thousands of real M&A situations to back your judgment, DealPilot, powered by M&A Science, gives you the deal guidance and advisor access to know which surprises you push through and which ones mean walk away.
____________________
This episode of M&A Science is presented by DealRoom.
DealRoom just automated Pipeline Management with AI so you can spend less time updating deals, and more time working them. Automatically push deal context from Outlook to DealRoom Pipeline and use AI to keep deal target data and tasks updated, so follow-ups never slip through the cracks. No manual logging. No stale pipeline data.
See for yourself: https://hubs.ly/Q045fXp50
____________________
Episode Chapters[00:00] Intro
[04:11] Birthday cake in the management presentation
[07:10] Recruiting bankers from the sell side
[09:04] Culture fit as a bid decision factor
[10:03] When the buyer dies before close
[11:46] Nine-month restart from scratch
[17:04] Management says the data does not exist
[18:39] Finding Susie and the 1980s IBM
[22:25] IP ownership surprise at signing
[24:43] Bootstrap founders and commitment signals
[27:43] When bankers favor PE over strategics
[30:40] 78-year-old seller, a fistfight, and an earn-out
[32:25] The 12-year sales cycle
[35:23] Teaching a CEO to speak like an investor
[43:14] Aviation IPO pulled mid-road show
[45:52] Background check kills the deal a week before close
[50:03] Forever corporation: how Chugach approaches M&A
[54:47] HVAC target heads toward bankruptcy mid-diligence
[55:59] Becoming the secured creditor to save the deal
-
Brent Baxter, Sam Delestienne, Steve Hoffman, John Strenger, and Matt Melsen
Winning a banker-run auction at 5% under the highest bid. Closing a deal when co-sellers have not spoken in months. Getting through 22 countries of employment complexity with a client who refused to work with EOR providers. Acquiring a Netherlands-based public company and discovering the due diligence documents were in Dutch. These are the problems that no playbook prepares you for. Four corp dev professionals share how they handled them, and what it cost when they got it wrong.
What You'll Learn
How to win a competitive auction when you're not the highest bidder What seller conflict at the closing table looks like (and how to get a deal back on track) When an employer of record works in a cross-border carve-out and when it creates permanent establishment risk Why management trust in the buyer can outweigh the highest bid number What a first European acquisition actually costs in compliance, legal, and cultural surprisesIf you're running deals where the numbers are right but the relationship isn't, or you're in a market you haven't operated in before, DealPilot, powered by M&A Science, connects you with advisors who have closed deals in exactly that situation.
____________________
This episode of M&A Science is presented by DealRoom.
DealRoom just launched the only MCP server built for Buyer-Led M&A™ — so your AI and your deal data finally work together. Connect Claude, ChatGPT, or Copilot directly to DealRoom and let your AI read your pipeline, analyze due diligence documents, and automatically write findings back.
See for yourself: dealroom.net/mcp
____________________
Episode Chapters[00:00] Intro
[03:12] Partners who came to blows over valuation
[03:37] The closing table walkout
[05:47] Every deal craters on Friday
[07:54] Why managing emotions is the hardest job after LOI
[13:30] A door blows off an Alaska Airlines jet mid-process
[16:00] Winning at $15M under the highest bid
[18:23] Trust and reputation as deal currency
[23:09] The "baby ugly" lesson
[25:06] Preempting banker processes
[32:14] What EOR is and when it works
[33:52] Permanent establishment risk with C-level hires
[34:48] CBA compliance across 22 countries
[40:38] First European cross-border acquisition
[42:38] Dutch documents and data residency surprises
[46:20] Why in-person matters more in Europe
[50:38] The $100M tax exposure that was not real
[55:57] Outro
-
Saknas det avsnitt?
-
Jörgen Wigh, CEO of Lagercrantz Group
Lagercrantz Group has completed 90+ acquisitions over 20 years and never sold one. CEO Jörgen Wigh runs 85 niche B2B companies under a 22-person headquarters with no integration, no exits, and no value realization targets.
This is Part 2 of 2. Part 1 covers the deal model, while Part 2 is the operating culture. Jörgen gets into how 85 autonomous companies are governed without a matrix structure, why this model exists almost exclusively in the Nordics, what makes a founder walk away from a signed deal twice, why Lagercrantz deliberately targets a 10% failure rate, and what he would do differently starting from scratch today.
What You'll Learn
How Lagercrantz governs 85 autonomous companies with 22 people at headquarters Why the person who sources the deal always stays on the board post-close Why the Nordic compounder model exists here and almost nowhere else What makes a founder walk away from a signed deal twice What a 10% deal failure rate looks like when it's working as intended Why building this from scratch today takes at least a decade How cross-border deals get done when the legal contracts run 30 pages instead of 300If you want to know how your team stacks up against the discipline Jörgen described across both episodes, take the M&A Competency Assessment.
____________________
This episode of M&A Science is presented by DealRoom.
DealRoom just launched the only MCP server built for Buyer-Led M&A™ — so your AI and your deal data finally work together. Connect Claude, ChatGPT, or Copilot directly to DealRoom and let your AI read your pipeline, analyze due diligence documents, and automatically write findings back.
See for yourself: dealroom.net/mcp
____________________
Episode Chapters[01:14] Introduction and Part 1 recap
[03:54] Deal governance: go/no-go process and board sign-off
[04:31] No handoffs: why the deal sourcer stays on the board post-close
[04:59] HQ structure: 22 people distributed across geographies
[07:05] Why so many compounder platforms come from the Nordics
[07:23] The cultural reasons: flat hierarchy, financial transparency, equality
[09:19] Nordic management style versus US hierarchy
[13:53] Cross-border deal friction: SPA length and legal complexity
[24:43] Programmatic serial acquirer versus roll-up
[25:18] The 100-day plan question: when Lagercrantz uses one and when it doesn't
[25:59] The Bergman & Beving spinout ecosystem: six listed companies
[26:45] Jörgen's role at Bergman & Beving and how conflicts are managed
[29:57] Geographic expansion: Germany, Netherlands, DACH, Northern Italy
[31:30] Starting from scratch today: why programmatic takes 10 years
[33:01] EPS as the true long-term performance driver, not stock price
[33:52] The perpetual ownership model and why it attracts certain sellers
[34:17] The founder who backed out twice, patience won the deal
[35:36] Failure rate: targeting 10%, what drives deals off course
-
Jörgen Wigh, CEO of Lagercrantz Group
Jörgen Wigh has been CEO of Lagercrantz Group (STO: LAGR-B) for over 20 years. In that time he completed 90+ acquisitions, built a portfolio of 85 niche B2B companies, and delivered 15 consecutive years of record earnings per share. No capital raises. No forced integration. No exits. The Nordic compounder model has quietly outperformed global markets for decades, and Lagercrantz is one of the longest-running, most disciplined examples of it in operation. In Part 1 of 2, Jörgen walks through the deal model behind that track record.
What You'll Learn
How Lagercrantz finds companies that are not for sale, and why the first call almost never closes a deal How Jörgen pushes for exclusivity in weeks when most sellers are running a banker-led process The earnout structure Jörgen uses to keep founders motivated for three years after signing What he says when PE shows up at 11x and the seller is tempted to take the bigger check Why founders walk away from more money for legacy preservation, and the conversation that earns it How to close 8 to 12 deals a year without breaking pricing disciplineIf you are holding pricing discipline against private equity and want to know whether your team would do the same, DealPilot, powered by M&A Science, runs the M&A Competency Assessment so you can benchmark deal judgment before the next term sheet.
____________________
This episode of M&A Science is presented by DealRoom.
DealRoom just automated Pipeline Management with AI so you can spend less time updating deals, and more time working them. Automatically push deal context from Outlook to DealRoom Pipeline and use AI to keep deal target data and tasks updated, so follow-ups never slip through the cracks. No manual logging. No stale pipeline data.
See for yourself at dealroom.net/pipelineai
____________________
Episode Chapters[00:00] Introduction
[05:48] Jörgen's path: analyst, McKinsey, and the Bergman & Beving spinout
[07:00] Coming back as CEO in 2006 and rebuilding from scratch
[09:21] Buy and hold, forever: how the model actually works
[11:21] What makes a company worth buying (and what kills it)
[12:28] A real deal: helicopter deck safety systems
[13:52] Who sells to Lagercrantz, and why
[15:44] The only two things Lagercrantz adds: energy and structure
[20:17] Finding companies that are not for sale
[22:36] When the banker shows up: getting exclusivity early
[23:55] Holding the line at 4-8x EBITDA when PE bids 11x
[25:09] The legacy preservation pitch that wins without matching price
[33:38] Earnouts that keep founders motivated for three years
[36:17] Running 85 companies with 22 people at HQ
[36:46] The only three functions Lagercrantz centralizes
[37:57] The annual MD conference and the peer network behind it
[40:13] 8 to 12 deals a year, one a month
-
Jim Buckley, VP M&A Integration at Coursera | Todd Manley, VP of Corp Dev Integration at Intel | Carey Pugh is Sr. Director, M&A Corporate Integration at Ansys | Mahesh Ganesan, Sr. Director, M&A Integration at UKG
Four integration leaders from Intel, Coursera, Ansys, and UKG debate what integration technology actually delivers versus what creates expensive overhead and where the real value leaks are. Todd Manley, Jim Buckley, Carey Pugh, and Mahesh Ganesan bring decades of deal experience to a conversation with no presentations and no curated answers.What You'll Learn
Why the diligence-to-integration handoff keeps failing and what actually fixes it How to evaluate integration technology without getting sold on complexity Where AI is genuinely useful in integration today and where it is not How to right-size your integration effort across multiple simultaneous deals Why knowledge loss is the biggest value leak in M&A and what to do about it How to handle post-close direction shifts when the acquired team changes course Why post-mortems matter and why most integration teams never run themIf you're running integration without a clear line between your workstreams and the original deal thesis, DealPilot has structured integration planning frameworks built on how practitioners at Intel, Microsoft, and UKG actually run it, so you stop rebuilding from scratch every deal.
____________________
This episode is sponsored by DealRoom
Get Insights from 100+ M&A Practitioners
See where M&A execution is evolving and where the competitive advantages are forming. Compare your approach to what's working for other teams.
Download the report: https://hubs.ly/Q03ZxRvD0
____________________
Episode Chapters[04:16] Introductions: Todd Manley, Jim Buckley, Carey Pugh, Mahesh Ganesan
[07:20] Integration philosophy: look back-to-forward, value drivers, keep it simple
[09:16] Culture as the foundation and what "walking the walk" actually means
[14:50] What separates teams that execute from teams that don't
[17:30] The diligence handoff problem: what gets lost and why
[23:56] Where integration technology helps and where it gets in the way
[24:39] AI in integration: real use cases vs. early innings
[31:02] The single source of truth problem
[32:38] Non-tech tools: simplicity as a method (5 slides, 5 bullets, 5 words)
[34:23] Audience Q&A: right-sizing diligence across 25 simultaneous deals
[40:22] Audience Q&A: managing post-close autonomy flips in integration
[43:03] Audience Q&A: sudden integration direction changes from leadership
[45:59] Biggest value leaks in M&A integration
[48:11] The case for pre-mortems and post-mortems
-
Tomer Stavitsky is SVP and Chief Corporate Development Officer at Omnicell (NASDAQ: OMCL)
Corp dev teams treat M&A and partnerships as separate tracks, but Tomer Stavitsky looks at them holistically. In this episode, he breaks down the partner-first approach: an acquisition framework for situations where the target isn't ready, the PE owner isn't selling, or your integration capacity isn't there. He walks us through structuring the partnership, keeping the acquisition thesis alive through execution, negotiating and defending a right of first refusal, and managing the three-way stakeholder dynamic without signaling the wrong things at the wrong time.
What You'll Learn
When partner-first is the right call and when it isn't How to keep the acquisition thesis alive through the partnership execution phase Managing the three-way dynamic between target leadership, the PE owner, and your own organization How to negotiate a right of first refusal and what happens when it gets tested Why teams pull the trigger too early and how to protect the process from internal pressure Applying partner-first to AI-era targets without getting caught in the hype cycleIf you're working through a partner-first deal, the M&A Science membership has frameworks and tools built for exactly this kind of situation. Learn more at mascience.com/membership.
____________________
This episode is sponsored by DealRoom
DealRoom's Buyer-Led M&A™ Summit is Back!
Join me at the summit on May 20, a free virtual event hosted by DealRoom covering AI, pipeline, diligence, and integration across the deal lifecycle. Sessions run 11:30 AM to 1:30 PM ET. Register here.
____________________
Episode Chapters[00:00] Introduction: Tomer Stavitsky's Background and the End-to-End Corp Dev View
[08:04] Building or Rebuilding a Corp Dev Function
[16:01] What Is the Partner-First Approach and When Does It Apply
[21:10] Mapping the Market and Deciding Who Stays on the Watch List
[24:13] Managing Multiple Targets Without Over-Committing
[27:48] Using Exclusivity as a Strategic and Protective Tool
[35:00] Managing the Three-Party Dynamic: Target Leadership, PE Owner, and Your Own Org
[37:58] The Real Story: How a Partnership Became an Acquisition (Including the Competitive ROFR Moment)
[42:41] The Most Common Mistake in Converting a Partnership to an Acquisition
[44:32] Applying Partner-First to AI-Era Targets
[49:21] What's the Craziest Thing You've Seen in M&A?
-
Chandradev Mehta, SVP Strategy and Business Development at Hexion Inc.
Chandradev Mehta, SVP Strategy and Business Development at Hexion Inc., breaks down how a commodity chemical company uses M&A to transform into a technology-enabled, chemistry-as-a-service business. He covers the acquisition of an AI and MarTech company, the build vs. buy vs. partner decision framework, integration planning discipline, banker selection, small deal execution, and JV governance.
What You'll Learn
How to build a genuine build vs. buy vs. partner framework and when each is right Why buying a commercialized or near-commercialized business changes your risk profile in ways that building from scratch can't (and never will) How Chandradev structures must-believes to maintain valuation discipline in competitive processes Why integration planning needs to start at IOI, not post-close What separates a banker worth your time from one running a numbers game Why small deals are frequently harder to execute than large ones (and how to protect against organizational deprioritization) How to negotiate JV governance before you need to unwind it____________________
If you're building an M&A capability from scratch or trying to get your team aligned on deal fundamentals, the M&A Fundamentals Track on DealPilot covers the full deal life cycle in roughly five hours, including vocabulary, process, and both sides of the table. Access it when you become an M&A Science member.
____________________
This episode is sponsored by DealRoom
DealRoom's Buyer-Led M&A™ Summit is Back!
Join me at the summit on May 20, a free virtual event hosted by DealRoom covering AI, pipeline, diligence, and integration across the deal lifecycle. Sessions run 11:30 AM to 1:30 PM ET.Register here: https://hubs.ly/Q0496h-s0
____________________
Episode Chapters[00:00] Introduction
[04:41] From Investment Banking to the Principal Side
[10:24] Using M&A to Transform Hexion
[11:01] Build vs. Buy vs. Partner Framework
[16:42] What Chemistry as a Service Actually Means
[23:43] Sourcing Deals: Push and Pull Model
[26:24] What Makes a Banker Actually Useful
[29:12] Valuation Discipline and Must-Believes
[36:21] Environmental Risk in Chemical Deals
[36:46] Why Small Deals Are Harder Than They Look
[41:21] Joint Ventures: Negotiate the Divorce First
[43:25] Execution Principles and Stakeholder Alignment
[47:08] Getting Deals Actionable
-
Keith Levy, Operating Partner at Sonoma Brands Capital
Most consumer brand founders think about exit as an event. Keith Levy thinks about it as a design requirement.
In the second of two episodes, Keith walks through what exit-ready actually looks like in CPG: the revenue and EBITDA thresholds that matter, why you have to get beyond the corp dev team to the operators who actually need what you're building, how capital gets wasted at every stage of a brand's lifecycle, and what the investments that produce exits have in common versus the ones that don't.
If you missed the first episode, it covers Keith's five-pillar CPG diligence framework and the Touchland and Bachan's case studies. Start there.
What You'll Learn
What revenue and EBITDA thresholds a consumer brand needs to attract a strategic acquirer. Why getting to corp dev is not enough, and how to reach the operators who actually need your brand. How capital gets wasted at each stage of a CPG brand's lifecycle. Why execution is where most investments fail, not the idea or the founder. What the celebrity founder model got wrong, and why copying a formula that worked once rarely works twice. What the investments that produced exits at Sonoma Brands had in common.____________________
If you're building a consumer brand toward exit or evaluating one for acquisition, DealPilot, powered by M&A Science, has the practitioner playbook for CPG exit positioning. Join at mascience.com/membership.
Already a member? The bonus conversation with Keith is live now: boards, earnouts, and the hardest lessons from six years backing consumer brands.
____________________
This episode is sponsored by DealRoom
DealRoom's Buyer-Led M&A™ Summit is Back! Join me at the summit on May 20, a free virtual event hosted by DealRoom covering AI, pipeline, diligence, and integration across the deal lifecycle. Sessions run 11:30 AM to 1:30 PM ET. Register here: https://hubs.ly/Q0496h-s0
____________________
Episode Chapters[00:00:01] Intro
[00:04:19] Day-to-day across 20+ portfolio companies
[00:05:43] When to lean in and when to stay out
[00:09:28] Pre-LOI landmines that kill deals early
[00:13:26] The CPG brand lifecycle: from first check to exit
[00:16:04] How capital needs change as a brand grows
[00:20:15] Execution is why most investments fail
[00:21:26] Capital allocation as the real test of a founder
[00:23:00] What it takes to position a CPG brand for strategic exit
[00:25:13] Big companies can't incubate brands — why that's your edge
[00:26:23] Why you have to get beyond the corp dev team
[00:29:48] What the investments that worked had in common
[00:33:43] Why investments fall apart after you cut the check
[00:35:16] The celebrity founder trap
[00:39:16] How the Sonoma deal funnel actually works
[00:45:22] What kills a deal at the investment committee stage
-
Keith Levy, Operating Partner at Sonoma Brands Capital
Keith Levy backed an exit of just under $1B and a $400M exit using the same five-pillar framework, and he starts with the founder every time. Finance comes last.
As Operating Partner at Sonoma Brands Capital, Keith has spent six years evaluating consumer brands across food, beverage, pet food, snacks, and cosmetics. Before that he was CMO at Anheuser-Busch through the $52B InBev deal, president of Royal Canin USA for Mars, and the strategic acquirer who led the Kind acquisition at Mars Wrigley. He knows what the data room doesn't show you, and this conversation is built around that gap.
The first of two episodes covers the full five-pillar CPG diligence framework and the Touchland and Boon's case studies. The second episode, out the following week, covers CPG brand lifecycle, exit positioning, and capital allocation.
What You'll Learn
Why the founder evaluation comes before the financials. How to read product-market fit the way an operator does, not a financial analyst. What a credible go-to-market strategy looks like vs. one that crashes in execution. Why supply chain control is now a diligence requirement, not an afterthought. How to get the right operators inside a strategic acquirer interested before a banker calls. The Touchland case study: under $1B exit in less than two years The Bachan's Japanese BBQ sauce case study: ($400M) exit with McCormick at the table.____________________
If you evaluate consumer brand investments and want a framework for the risks the model won't surface, DealPilot, powered by M&A Science, has the practitioner playbook. Join at mascience.com/membership.
Already a member? The bonus conversation with Keith is live now: boards, earnouts, and the hardest lessons from six years backing consumer brands, exclusively for M&A Science members.
____________________
This episode is sponsored by DealRoom
DealMax starts Monday.
Find us at the Aria
DealRoom: Booth 109,
M&A Science: Booth 208.
Kison will be signing copies of Buyer-Led M&A all three days, and we've got a candy bar and swag worth stopping for. Then, join us monday night for a happy hour, RSVP here: https://hubs.ly/Q043VnNH0____________________
Episode Chapters[00:00:00] Intro
[00:02:02] Keith's background overview (24 years at AB, $52B InBev deal – narrated)
[00:05:40] Running Royal Canin and joining Mars / Mars Wrigley
[00:08:45] Why Mars acquired Kind
[00:09:15] What is Sonoma Brands and how Keith got there
[00:10:17] The Budweiser CMO era & favorite ads
[00:15:12] The Mars / Wrigley China integration
[00:23:15] How Sonoma Brands evolved from venture to growth equity
[00:25:11] Why deals don't work and what Sonoma changed
[00:27:12] The Keith Levy CPG diligence framework
[00:30:04] How to evaluate a founder
[00:35:40] What product‑market fit actually looks like
[00:38:32] Touchland: under $1B exit in two years
[00:39:05] Go‑to‑market: sequencing channels & steady growth
[00:41:10] Why TAM is just a sniff test
[00:43:31] Why how you make the product matters more than you think
[00:47:08] The real value an operating partner brings
-
Matt James, EVP, CFO & Chief Acquisition Officer at Oakbridge Insurance
Roll-up platforms that skipped real integration are getting exposed when they go to market. Buyers want proof of organic growth, clean data, and a platform that actually functions as one. A lot of processes are breaking down because those proof points aren't there.
Matt James co-founded Oakbridge Insurance in 2020 and has since closed 60+ acquisitions, integrating 100% from day of close. This conversation covers how he built that system, what went wrong with billion-dollar competitors, and what he would fix first if he walked into a revenue-aggregating roll-up right now.
What You'll Learn
Why multiple arbitrage is gone, and what buyers are scrutinizing instead How Oakbridge evaluates cultural fit before any financial criteria What a failed billion-dollar roll-up sale process looks like from the inside Building integration continuity from LOI through 90 days post-close How distributed equity drives buy-in across an acquired organizationIf you're evaluating targets and want to know if they're integration-ready pre-LOI, the Intelligence Hub can help you score cultural fit, data readiness, and technology maturity. Join the professional membership at mascience.com/membership.
____________________
This episode is sponsored by DealRoom
DealRoom's State of M&A Report gives you data to back up your M&A priorities.
The State of M&A Report reveals the gap between what teams think matters and where the real bottlenecks are.
Download it now to get expert insights: https://hubs.ly/Q03ZxRvD0____________________
Episode Chapters
[00:03:00] Introduction & Matt's Background
[00:05:00] How Buyer Diligence Has Shifted
[00:06:00] Organic vs. Inorganic Growth and Why It Matters
[00:11:00] The Four-Criteria Deal Evaluation Framework
[00:14:00] Validating Cultural Fit Before LOI
[00:17:00] Deal Structure: Equity, Earnouts, and Alignment
[00:20:00] What Billion-Dollar Platforms Got Wrong
[00:26:00]Building the Integration System at Oakbridge
[00:31:00] Bridging Diligence and Integration
[00:38:00] Data Infrastructure: Databricks, Power BI, and Why It's Worth It
[00:45:00] Building Proprietary Deal Flow
[00:52:00] First Moves When Integration Is Broken
-
Dan Caruso, Managing Director, Caruso Ventures; Founding CEO of Zayo Group
This is Part 2 of our conversation with Dan Caruso, founder and former CEO of Zayo Group. Be sure to start with Part 1. It covers the Zayo thesis, deal sourcing, structure, and the negotiation playbook, whereas this episode picks up at the execution.
Part 2 is about the equity value-creation framework Dan built at Zayo, applying the same IRR math PE firms use for their portfolio companies to daily operating decisions. It replaced budgets and tied every compensation decision to a single equation. It ends with the exit and how Dan put together a competing bid after a buyer consortium locked up the debt market.
What You'll Learn
How Zayo's integration process matured across 45 deals + where it broke post- IPO The equity value creation model: the IRR metric that replaced budgets and tied compensation to a single equation Negotiation tactics: countering lower, manufacturing urgency, and splitting the CEO from their investor at the table Culture during integration: one culture, take it or leave it IRR compression as a sell signal and how Dan acted on it before most saw it coming The sell process: engineering a competing bid after buyers locked up the debt market The ICG deal: $8.7M in, $250M out, 18 monthsWant to apply Dan's framework to your own business? The Intelligence Hub has the Equity Value Creation Operating Model, a step-by-step guide to replacing budget-based management with IRR as your operating compass. Access here.
____________________
This episode is sponsored by DealRoom
M&A Science is heading to ACG DealMax in Las Vegas, April 27–29 and we'd love to see you there. Stop by the booth for a book signing, swag, and a look at what the M&A Science and DealRoom teams have been building.
Learn more and save the date: https://hubs.ly/Q043VnNH0____________________
Episode Chapters[00:02:28] Public company vs. private: what changed about deal execution.
[00:03:40] Negotiation tactics: countering lower, manufacturing urgency, the CEO-investor wedge.
[00:08:15] Integration maturity: how execution evolved across 45+ deals.
[00:18:43] Culture: join us or don't.
[00:20:35] Going public: super voting shares, activist investors, and the PR game Dan skipped.
[00:24:40] Post-IPO talent drain and what Dan would restructure in management equity.
[00:29:26] When to sell: reading value compression.
[00:33:03] The sell process: competing bid against a cornered debt market.
[00:39:18] The equity value creation model: replacing budgets with IRR.
[00:43:29] IRR as a real-time operating metric.
[00:49:50] Cruso Ventures, quantum, space, and Boulder Roots Music Fest.
[01:01:06] The ICG deal: $8.7M in, $250M out
-
Dan Caruso, Managing Director, Caruso Ventures; Founding CEO of Zayo Group
Dan Caruso built Zayo from a startup into a $14B+ bandwidth infrastructure platform through 45 acquisitions. In Part 1, he walks through the full buyer-led playbook: how the thesis was built on a contrarian bet that everyone else got wrong, how proprietary deals were sourced through early relationship-building, and why fast integration wasn't a reputation problem — it was a competitive advantage.
He also breaks down the metric trap most roll-up operators fall into: mistaking EBITDA growth for true value creation. If your board is tracking acquisitions individually or your deal structure is loaded with earnouts, this conversation will challenge how you're running the program.
What you'll learn:
How to identify and build a contrarian acquisition thesis with investor alignment Why proprietary deal flow is a brand and relationship problem, not a sourcing problem How Zayo executed an unsolicited, fully funded offer on a larger public company — and won Why tracking individual acquisitions kills synergies in a roll-up When earnouts hurt more than they help — and what to use instead How clean, all-cash offers win on certainty, not priceDan's approach to thesis validation, investor alignment, and platform value creation is documented in the Roll-Up Readiness Assessment inside the Intelligence Hub, a stage-gated guide built directly from this conversation. Access inside the Intelligence Hub — → Access inside the M&A Science Hub — members only.
____________________
This episode of M&A Science is presented by DealRoom.
DealRoom just automated Pipeline Management with AI so you can spend less time updating deals, and more time working them. Automatically push deal context from Outlook to DealRoom Pipeline and use AI to keep deal target data and tasks updated, so follow-ups never slip through the cracks. No manual logging. No stale pipeline data.
See for yourself: https://hubs.ly/Q045fXp50____________________
Episode Chapters[00:02:00] Introduction: Dan Caruso and the Zayo Story
[00:03:51] Background: From Ma Bell to MFS to Level Three
[00:08:58] Lessons from WorldCom: What Fake Value Creation Looks Like
[00:10:35] What First-Time Acquirers Get Wrong
[00:12:39] Building the Zayo Thesis: Fiber Orphans and Accidental Owners
[00:17:20] Raising Capital When You Have a Track Record
[00:23:50] What Must Be True for the Thesis to Work
[00:26:54] Why EBITDA Doesn't Measure Value Creation
[00:29:15] The Danger of Tracking Acquisitions Individually
[00:31:17] What Actually Drove Zayo's Success
[00:36:10] Convincing Sellers: Proprietary Sourcing and Relationship Strategy
[00:45:30] The Above Net Acquisition: Unsolicited, Fully Funded, at a Conference
[00:51:02] Negotiation Tactics: Unpredictability, Silence, and Team Play
[01:02:16] Deal Structure: Why Zayo Avoided Earnouts
[01:03:56] Clean Cash Offers and Certainty of Close
-
Rodrigo Dominguez Sotomayor, Partner at White & Case LLP
Most US buyers approach Latin America M&A the same way they do a domestic deal — optimize the process, close fast, move on. That approach gets deals killed.
Rodrigo Dominguez Sotomayor, Partner at White & Case LLP, has spent 25 years closing transactions across every major Latin America market. In this episode, he walks through what actually determines outcomes: antitrust consent timelines, labor regimes that make post-close restructuring expensive, and the relationship dynamics that can unwind a billion-dollar deal a week before signing.
What You'll Learn In This Episode:
How a PE fund lost a billion-dollar deal over 2% — and why it was avoidable Why LatAm antitrust approvals can take up to nine months and how to plan around them What no employment-at-will actually costs you post-close Why showing up to a LatAm auction without reps & warranties insurance is a disadvantage How to negotiate with family founders when price isn't what closes the deal Why 80% of Latin America deals now run through auctionsYour standard diligence process will miss things that kill LatAm deals — statutory severance you didn't model, title searches that go back a hundred years, antitrust consent timelines that block close for months, auctions where R&W insurance is already expected.
Running diligence on a LatAm target right now? The M&A Science Hub has two resources built directly from this episode — the LATAM Diligence Delta Checklist and the Latin America M&A Entry Playbook — plus an AI tutor trained on 400+ practitioner conversations you can pressure-test your current deal against.
Members get access before the episode goes public. → Access inside the Intelligence Hub — members only.
____________________
This episode is sponsored by DealRoom
Stop juggling six different tools to run one deal. DealRoom brings pipeline management, diligence tracking, document sharing, and team collaboration into one platform. Purpose-built for M&A teams who need to move fast without losing control. request your demo today: https://hubs.ly/Q03ZMvQX0
____________________
Episode Chapters[00:04:26] Rodrigo's background: 25 years across Latin America M&A
[00:06:57] How a cross-border acquisition actually starts
[00:10:17] Bilateral deals and family-owned businesses
[00:12:52] Reading the room: when not to push on numbers
[00:14:12] The billion-dollar deal that fell apart over 2%
[00:20:02] Antitrust consent regimes across LatAm
[00:29:49] The union leader story
[00:27:14] Labor, employment, and statutory severance
[00:34:04] Reps & warranties insurance: now standard in LatAm
[00:38:44] Auction vs. bilateral: the 80/20 split
[00:44:01] FinTech opportunity in Latin America
[00:48:05] NVCA forms and deal documentation
[00:52:48] Post-close integration: what actually determines success
[00:55:51] Craziest Thing in M&A
-
Chrissy Cox, VP & Head of Corporate Development, Booz Allen Hamilton
Booz Allen Hamilton didn't build one of the most active acquisition programs in federal tech by waiting for banker inbounds. They built it by showing up years before anyone else.
Chrissy Cox has built Booz Allen's corporate development function from scratch and done it twice. Her team was named Deal Team of the Year by the Association for Corporate Growth, and under her leadership, roughly 80% of their acquisitions come from companies they already have a relationship with. That's not luck, it's a system.
In this episode, she breaks down exactly how that system works — from pipeline development to cultural diligence to integration ownership — and what most corp dev teams get wrong before they ever get to LOI.
What You'll Learn in This Episode How to build a proprietary pipeline that makes you the preferred buyer before a process starts The specific cultural fit questions Chrissy asks — and the one answer that ended a deal on the spot Why she tells founder-led sellers to hire their own banker, even on proprietary deals How to navigate a carve-out when scope is impossible to fully define upfront When spinning out a business beats building it internally The three mistakes that derail most corp dev functions before they find their footingThis episode is sponsored by M&A Science Intelligence Hub
If you're trying to move from cold outreach to genuine relationship-building with targets, the Intelligence Hub has the Partner-First Acquisition Evaluation Playbook — a practitioner-built framework for structuring pre-acquisition partnerships, evaluating targets through the lens of existing relationships, and moving from partner to acquirer with conviction. Become an M&A Scientist at www.mascience.com/membership
_____________________
This episode is also sponsored by DealRoom
The best M&A teams close deals faster...not because they work harder, but because they have better systems. DealRoom helps you manage your entire deal lifecycle from target identification through close. No more hunting for documents or wondering what's blocking progress.
Request a Demo today: https://hubs.ly/Q03ZMvQX0
____________________
Episode Chapters[00:00:00] Intro
[00:04:20] Chrissy Cox's path into M&A
[00:05:04] Building Booz Allen's corp dev function
[00:10:32] How Booz Allen builds a proprietary deal pipeline
[00:15:08] The partner-first approach to acquisitions
[00:20:31] When founders should consider selling
[00:23:49] Why culture can kill a great deal
[00:29:40] Carve-out lessons from the PAR Government deal
[00:33:24] Why founders should hire bankers
[00:43:43] Integration: protect the secret sauce
[00:48:01] The biggest mistakes in corporate development
[00:49:33] The craziest thing about M&A
-
Nathan Rust, Senior VP of Corporate Development, Salas O'Brien
Salas O'Brien has completed 30+ mergers with a 100% success rate and 93% cumulative leadership retention.
That doesn't happen by accident.
Nathan Rust, Senior VP of Corp Dev, explains the system behind those numbers. He shares how they screen bad fits on the first call, why their CEO meets every employee from acquired firms, and how a founder-driven sourcing flywheel attracts inbound deals.
In this episode: You'll learn how they screen 200+ opportunities a year down to the ones worth closing, why their initial diligence list is 10 questions, how reverse due diligence works as a real screening tool, and what CEO-led integration meetings mean for retention.
The core argument: Cultural fit isn't a soft metric. Believe it or not, it's the primary filter for deals. EBITDA tells you what you're buying, but people tell you whether it survives.
If you run corp dev at a people-intensive business and wonder why your post-close retention doesn't match your pre-close promises, this episode is for you.
What You'll Learn in This Episode Why retention is one of the most overlooked risks in M&A How cultural compatibility is assessed during early conversations Why many buyers damage their reputation by retrading deals How equity rollovers align incentives between buyers and sellers Why simplicity in diligence often produces better results How direct outreach and referrals drive proprietary deal flow The role of reverse diligence in evaluating buyer credibility____________________
This episode is sponsored by M&A Science
If you're struggling to retain founder-led leadership teams post-close, the Hub has frameworks for cultural integration and leadership retention to help you actually deliver on what you promised at signing. Get access at www.mascience.com/membership
_____________________
This episode is also sponsored by DealRoom
The best M&A teams close deals faster...not because they work harder, but because they have better systems. DealRoom helps you manage your entire deal lifecycle from target identification through close. No more hunting for documents or wondering what's blocking progress.
Request a Demo today: https://hubs.ly/Q03ZMvQX0
____________________
Episode Chapters[00:04:40] Nathan's Background & How It Shaped His M&A Philosophy
[00:09:25] Why People Are the Primary Deal Filter
[00:11:23] The Three Screening Criteria on Every First Call
[00:16:51] Earnouts, Equity Rollover, and Employee Ownership
[00:21:21] Deal Sourcing: Employee Referrals, Buy-Side Reps, Direct Outreach
[00:33:37] How Introductory Calls Actually Run (And Why They're 90% Personal)
[00:42:10] The 10-Question Diligence List & Reverse Due Diligence
[00:47:50] Valuation Philosophy — Fair Offers, No Retrading
[00:51:10] ESOP Deal Complexity & The Charlotte Deal Story
[00:55:00] Integration: Why the CEO Meets Every Employee
[00:57:44] The Craziest Thing in M&A
-
Mauro Sambati, Partner – Gianni & Origoni
Donato Romano, Partner – Gianni & Origoni
Italy remains one of Europe's most attractive markets for foreign investment. But cross-border deals in Italy are shaped by regulatory scrutiny, strict labor laws, and unique cultural dynamics that many investors underestimate.
In this episode, Mauro Sambati and Donato Romano, Partners at Gianni & Origoni, explain what it truly takes to structure and close successful transactions in Italy.
What You'll Learn in This Episode Why Golden Power must be structured as a condition precedent before closing How strict Italian labor laws impact asset deals and post-closing restructuring The differences in negotiation styles between US, UK, Japanese, and Korean buyers How minority governance protections are typically structured in Italy The evolution from closing accounts to lockbox pricing mechanisms
This episode offers a practical perspective for M&A leaders navigating complex decisions where clarity and conviction matter as much as valuation.
Listen to the full episode to learn how strategic focus can define billion-dollar outcomes.
_____________________
If you're structuring a cross-border deal in Europe, the Hub has practitioner-built playbooks and AI-assisted deal guidance to help you navigate regulatory clearance sequencing, minority governance, and founder transition dynamics. Become an M&A Scientist at www.mascience.com/membership
_____________________
This episode is also sponsored by DealRoom
DealRoom's State of M&A Report gives you data to back up your M&A priorities.
The State of M&A Report reveals the gap between what teams think matters and where the real bottlenecks are.
Download it now to get expert insights: https://hubs.ly/Q03ZxRvD0
____________________
Episode Chapters[00:02:59] Guest Backgrounds & Italian Legal Market – Introduction to the partners at GOP and how Italy's full-service law firms support cross-border buyers.
[00:08:47] Lessons from Early Cross-Border Deals – Why negotiation strategy, communication, and cultural awareness matter more than technical drafting.
[00:11:03] Golden Power Regulations Explained – How Italy's FDI regime works, what sectors trigger review, and how geopolitical shifts expanded scrutiny.
[00:17:40] Managing Regulatory Risk & Deal Timing – Practical steps for foreign buyers to navigate filings, conditions precedent, and approval timelines.
[00:21:54] Cultural Differences in Buyer Behavior – How Japanese, Korean, UK, and US acquirers differ in speed, hierarchy, and decision-making.
[00:29:46] Common Pitfalls for US Buyers in Italy – Employment law constraints, founder influence, and the risks of moving too fast post-acquisition.
[00:35:40] Deal Sourcing in Italy – The shift from investment bank–led processes to lawyer-driven origination and evolving private equity activity.
[00:42:20] Lockbox vs. Closing Accounts – How Italian deal structures have evolved, why private equity favors lockbox, and the mechanics behind each method.
[00:48:50] Earnouts & Governance Tensions – Structuring short-term earnouts, aligning incentives, and balancing control with seller protections.
[00:57:35] Labor Law & Retention Realities – Why layoffs are complex in Italy, union consultation requirements, and the cultural importance of employee continuity.
[01:03:08] The Craziest Thing in M&A – An Italian founder let employees vote on the preferred buyer, choosing cultural fit over a higher private equity offer.
-
President & CEO of The ChemQuest Group. Previously, as VP of Corporate Strategy at Milliken & Company
When it comes to billion-dollar deals, success depends less on how much analysis is done and more on how clearly the organization aligns around what truly matters.
In this episode of the M&A Science Podcast, Robert Lovegrove, President & CEO of The ChemQuest Group. Previously, as VP of Corporate Strategy at Milliken & Company, shares how one of the company's largest acquisitions was shaped by focus, discipline, and internal alignment. Rather than overwhelming the process with more diligence, leadership centered the decision around four core questions that clarified risk, built conviction, and guided a confident go / no-go decision.
Robert also explains how adjacency-based M&A reduced execution risk, why trust mattered more than price in winning the deal, and how treating culture as a deal consideration—rather than an integration afterthought—helped unlock long-term growth.
What You'll Learn in This Episode How to create executive alignment in high-stakes M&A decisions The four questions that anchor go / no-go decisions at scale Why adjacency-driven M&A improves confidence and execution How trust can outweigh price in competitive deal processes Why culture should be treated as a deal risk, not an HR issue
This episode offers a practical perspective for M&A leaders navigating complex decisions where clarity and conviction matter as much as valuation.
Listen to the full episode to learn how strategic focus can define billion-dollar outcomes.
_____________________
This episode is brought to you by the M&A Science Intelligence Hub.
You know that feeling when you're deep in a deal and something doesn't sit right, but you've already invested weeks into it? The Intelligence Hub helps you think like someone who's walked away from bad deals before — because they have. Pattern recognition from 400+ practitioner interviews, with citations back to the exact conversation. Join the professional membership at mascience.com/membership.
_____________________
This episode is also sponsored by DealRoom
Stop juggling six different tools to run one deal. DealRoom brings pipeline management, diligence tracking, document sharing, and team collaboration into one platform. Purpose-built for M&A teams who need to move fast without losing control.
Request your demo today:https://hubs.ly/Q03ZMvQX0
____________________
Episode Chapters[00:04:24] From Engineer to Strategy Chief – Robert Lovegrove's path from mechanical engineer to VP of Corporate Strategy at a 160-year-old family-owned industrial.
[00:05:23] Designing for Dividends – Reorienting corporate strategy around stable dividend growth instead of pure enterprise value expansion.
[00:09:24] Portfolio Surgery – Using market attractiveness vs. competitive position to rebalance cyclicality and reshape capital allocation.
[00:10:26] The Adjacency Map Framework – Defining "right-to-win" expansion zones across technology, geography, business model, and customer verticals.
[00:13:38] Tollgates Before IOI – Aligning board approval and capital allocation early to enter deals with conviction and certainty.
[00:15:56] Day Two Strategy Integration – Building 7-year strategic plans with acquired teams to create solution co-ownership post-close.
[00:21:07] Soft vs. Hard Synergies – Prioritizing growth conviction and scalable models over traditional cost-cutting synergies.
[00:30:27] Winning with Emotional Alignment – Provoking sellers with vision-led conversations that secure management support—even without the highest bid.
[00:38:09] Four Questions Behind a Billion-Dollar Deal – Testing technology defensibility, customer concentration risk, growth durability, and talent retention.
[00:45:37] Capital Allocation Battles – How M&A competes with organic investments across 20 SBUs and dozens of profit centers.
[00:51:16] Customer Awareness as Risk Control – Using third-party market interviews to prevent post-close revenue surprises.
[00:58:50] The Craziest Thing in M&A – An 11th-hour closing crisis triggered by a messy divorce and disputed property title nearly derailing the deal
-
Birgitta Elfversson, Non-executive director at Netlight Consulting AB
Lars Elfversson, VP/Co-Founder, Netlight Consulting AB
In fragmented industries, roll-ups are one of the most powerful strategies available. But high-volume acquisition programs come with hidden risks. Without discipline, complexity can quickly overwhelm value creation.
In this episode, Birgitta Elfversson, Non-executive director at Netlight Consulting AB, and Lars Elfversson, VP/Co-Founder, Netlight Consulting AB, share hard-won lessons from building and governing multiple roll-up platforms. Drawing on their experience as operators, board members, and investors, they outline the structural guardrails required to execute consolidation strategies successfully.
The conversation goes beyond sourcing and valuation to issues that determine long-term success.
What you'll learn:
Why small pipelines create dangerous decision pressure How subtle drift reshapes portfolios over time The importance of defining and defending an acquisition framework Why most roll-ups fail because of people, not numbers How inconsistent integration across acquisitions compounds complexity Why clarity (whether full, partial, or no integration) must be defined early and communicated clearlyThey also discuss governance discipline, board oversight, founder psychology, and the realities of market timing and exit decisions.
If you're building or advising a roll-up platform, this episode is a practical guide to avoiding deal fever and installing the guardrails that protect strategy.
_____________________
This episode is sponsored by DealRoom
The best M&A teams close deals faster...not because they work harder, but because they have better systems. DealRoom helps you manage your entire deal lifecycle from target identification through close. No more hunting for documents or wondering what's blocking progress. Request a Demo today
____________________
Become an M&A Scientist: www.mascience.com/membership - $995/year for full access to the Intelligence Hub
____________________
Episode Chapters[00:02:38] From Organic Builder to PE Rollups – Lars and Birgitta contrast building companies 100% organically vs. scaling through programmatic M&A.
[00:10:07] Validating the Rollup Thesis – How PE firms test market fundamentals, recruit operators, and pressure-test early industry hypotheses.
[00:13:02] Defining the Acquisition Framework – Setting guardrails on size, profitability, services, and integration logic before chasing deals.
[00:15:46] Avoiding Deal Fever with Massive Pipelines – Why long target lists prevent desperation, strategy drift, and "must-win" mistakes.
[00:21:07] Saving Your Silver Bullets – How board members influence management without overplaying authority or derailing alignment.
[00:23:43] Why Deals Go Off the Rails – How incentives, scarcity, and human bias quietly nudge teams away from original criteria.
[00:29:10] Picking the Right Companies to Buy – The three core filters: business model, size compatibility, and profitability profile.
[00:46:06] Integration Depth Drives Exit Value – Why partial integration destroys valuation and how buyers now scrutinize ERP, systems, and operational cohesion.
[01:01:56] Signing 27 Deals in One Day – A firsthand look at high-velocity rollups and the operational intensity behind scaling platforms.
[01:02:37] The Craziest Thing in M&A – Accounting "creativity," forward-recognized revenue, and a deal so distorted it forced a divestiture and loss.
____________________
Questions, comments, concerns?
Follow Kison Patel for behind-the-scenes insights on modern M&A. -
No guest today. No interview. Just Kison talking directly to you.
After 400 episodes and nearly 100 founding members, Kison wanted to give you a real update - where M&A Science has been, what we're building, and where this is going.
In this episode:
Why episodes are moving to Thursdays How the Intelligence Hub actually works (and why it's better for M&A than ChatGPT) What's coming next: Buyer-Led M&A Certification and Enterprise Intelligence Hub Ways to get involved: Membership and the Deal Leader programIf you've been part of this journey, this one's for you.
Ready to join? Become an M&A Scientist: www.mascience.com/membership - $995/year for full access to the Intelligence Hub, live sessions, and practitioner community.
Limited time: Become a member by March 1st, get $100 to the M&A Science shop.
Want to contribute? Become a Deal Leader (20+ deals required): Email [email protected]
-
Ciprian Stan, M&A Integration Manager at SALESIANER Gruppe
Too many deals fail not because the strategy was wrong, but because execution realities surfaced too late.
Ciprian Stan, M&A Integration Manager at SALESIANER Gruppe, is back for part 2. In this portion of the interview, he shares a practitioner's perspective on why integration must inform strategy before a deal is signed, never after.
The conversation explores why cultural non-negotiables rarely surface through checklists, how trust shapes execution outcomes, and why early commitments must survive post-close reality. Ciprian explains why integration leaders need to ask smarter questions, and how technology (including AI) should support judgment rather than replace it.
This episode is for corp dev leaders, integration managers, and executives who want fewer surprises after close and more durable deal outcomes. If you missed part 1, make sure to catch that first, where we talk about building preliminary integration plans during diligence and why customization beats templates. Then come back for the trust and execution reality in part 2.
Why execution constraints should shape deal strategy early How cultural non-negotiables actually surface in diligence The role of trust in integration success Why earnouts often fail when execution reality changes How AI can support integration thinking—if used responsibly
Things You'll Learn_____________________
Hitting pipeline or execution challenges?
The State of M&A Report shows what other deal teams are dealing with and how they're adapting.
Download the full report today: https://hubs.ly/Q03ZxRvD0
____________________
Episode Chapters[00:04:29] Knowing When to Kill a Deal – Why smart executives walk away when sunk costs, ego, and reputation start driving bad decisions.
[00:05:12] Integration Non-Negotiables – The critical role of a "red team" and trusted challengers in stress-testing deal assumptions early.
[00:05:50] Custom Diligence, Not Checkbox M&A – How tailoring diligence to the deal thesis prevents wasted effort and missed risks.
[00:06:25] The Thousand-Checklist Trap – Why dumping massive integration plans on teams backfires—and how to narrow focus without losing rigor.
[00:07:28] Diligence Should Shape Integration – Aligning integration plans directly to value drivers uncovered during diligence.
[00:10:17] Pre-Signing Integration Plans – Why having a preliminary integration roadmap before signing is essential to execution and accountability.
[00:11:55] Trust Is the Real Integration Currency – How trust matters more after close than before—and how it's easily damaged.
[00:15:18] Earn-Outs That Blow Up Trust – How overlapping acquisitions can quietly sabotage earn-outs and poison seller relationships.
[00:19:29] When Culture and Ops Both Fail – The red-line rule: why deals with both operational and cultural issues should not get done.
[00:23:03] AI, IP, and the Future of M&A Work – Why technology is becoming commoditized and experience-driven judgment is the real differentiator.
[00:33:58] Defining IP in the Tech Era – Debating whether intellectual property lies in the technology itself or in unique, qualitative content and human insight. I have a question like what IP
[00:47:10] The Craziest Thing in M&A – A deal dies after buyers are forbidden from entering one room during diligence—raising irreversible trust red flags.
____________________
Questions, comments, concerns? Follow Kison Patel for behind-the-scenes insights on modern M&A.
- Visa fler
